,
A US based global biopharmaceutical company approached Freyr for pre-IND meeting request submission scope to USDFA.
The client had limited understanding in this requirement and notification towards and wanted an expert in this domain. With Freyr’s Regulatory support the client received the best Regulatory support until FDA submission.
Download the proven case now.
Fill the form below to download the Case Study
